Contrast imaging represents a new and exciting application to the field of ultrasonography. As with the introduction of new imaging modes (i.e., color flow imaging) or examination (i.e., stress echocardiography), a learning phase will be necessary. For optimal contrast use, it is important to understand what microbubbles are designed to enhance, how to optimize the imaging system, and how to interpret the resulting images. Types of administration and use of the agents are also important to understand. This article will offer technical tips and helpful hints to shorten the sonographer's learning curve to successfully implement optimal contrast imaging for cardiac applications.
In 1968, Gramiak and Shah 1 first described an injection of saline into the aorta during cardiac catheterization as a use of a contrast agent in echocardiography. The result was contrast enhancement in the heart. During the 1970s, agitated saline became accepted for right heart opacification to assess suspected atrial shunts. Agitated Renografin was also used for cardiac and aortic opacification. In the 1980s, work began on transpulmonary contrast agents for left ventricular opacification (LVO) and endocardial border delineation (EBD). Early work began with intracoronary injections in dogs and subsequently progressed to human subjects. By 1994, Albunex was approved by the Food and Drug Administration (FDA) for LVO via peripheral intravenous injections.
Unfortunately, Albunex did not produce reliable homogeneous cavity opacification in all patients. However, this "failure" marked the beginning of the development of newer second-and third-generation agents. These new agents are composed of different types of shells and are filled with various gases. The addition of perfluorocarbon gases was critical, as the gas diffuses out of the bubble shell more slowly, allowing the bubbles to persist in the blood pool much longer than the air-filled Albunex bubble. Optison and Definity are FDA-approved second-generation agents that are currently available (with Imagent pending) for LVO in the United States and Europe. Additionally, Levovist and Sonuvue are available in Europe. All of these agents have been shown to be safe and effective in routine transthoracic imaging. [2] [3] [4] Future agents are being developed that use different types of shell coatings and various gases within the bubble for increased persistence in the circulation.
Ideal Contrast Agent Characteristics
The ideal ultrasound contrast agent must have certain components. It must be safe, have few or no side effects, and be simple to prepare and administer. It must be smaller than 7 microns to successfully transit the pulmonary capillary bed to opacify the left side of the heart. Importantly, and in this era of cost containment, it should be cost-effective and the resulting images must offer an incremental benefit in quality over the non-contrast-enhanced images. It must be stable and produce reliable results in all patients. The bubble's shell and gas density should provide increased resilience to the effects of ultrasound power and prolonged duration of chamber opacification to provide sufficient time for imaging. The search for the ideal contrast agent is a challenge that multiple pharmaceutical companies have undertaken.
Imaging studies show that 10% to 15% of routine transthoracic imaging is technically difficult. Suboptimal echo "windows" are often the result of obesity, chest deformities, surgical scars, and settings in which studies are performed, such as the intensive care unit and critical care unit. 5, 6 Transpulmonary contrast agents now available can help to overcome these barriers by providing improved EBD and prolonged LVO. [7] [8] [9] 
Uses of Contrast
The most popular current use of left ventricular contrast agents includes EBD and LVO. Other applications include Doppler enhancement, thrombus detection, and, in the future, myocardial contrast enhancement.
WHY IS EBD/LVO USEFUL?
Assessment of left ventricular function is one of the most common reasons to request an echocardiogram. Contrast enhancement of the left ventricle improves left ventricular EBD, which in turn leads to more accurate assessment of left ventricular systolic function and chamber dimensions, especially in patients with technically difficult images. Figure 1 demonstrates the improvement in EBD following contrast administration in a patient with technically difficult images. The use of contrast can allow for a more accurate assessment of left ventricular volumes and ejection fraction especially when measuring the biplane Simpson's method. 10 Assessment of left ventricular function can be particularly important for patients in the intensive care unit because they often have poor image quality due to mechanical ventilation or inability to alter their position in bed. It has been shown that contrast imaging can provide an average increase of 4.5 segments over non-contrast imaging in the intensive care unit setting. 11 A related application can be the use of contrast during stress echocardiography, either through exercise or pharmacological. [12] [13] [14] During stress echocardiography, it is especially important to clearly visualize each endocardial segment at each stage of the protocol. The use of contrast in stress echo thus optimizes diagnostic accuracy. Figure 2 demonstrates the use of contrast in an exercise stress echocardiogram. Contrast echocardiography has been proven to reduce interobserver variability and allows less experienced readers (when compared to experienced readers) to achieve better agreement for interpreting left ventricular wall motion. Increased left ventricular border delineation also increases reader confidence, resulting in greater diagnostic accuracy. 15 The use of contrast has the potential to improve the diagnostic accuracy of stress echocardiography by a 2.7-fold increase over those studies deemed as nondiagnostic. 16 
DOPPLER ENHANCEMENT WITH CONTRAST AGENTS
Agitated saline has often been used to increase detection of tricuspid regurgitant jets when employing continuous wave Doppler. Current contrast agents that allow both right and left heart opacification can provide jet enhancement of tricuspid regurgitation, pulmonary venous flow, aortic stenosis, aortic insufficiency, mitral regurgitation, and prosthetic valve velocities. 17, 18 In these applications, a smaller amount of contrast is administered to improve spectral Doppler tracings and facilitate quantitative measurements. Figure 3 is an example of a patient with tricuspid regurgitation in which a contrast injection clearly enhanced the continuous wave jet envelope and allowed for better assessment of right ventricular systolic pressures. Color flow imaging for valvular regurgitation can also be enhanced when using contrast agents, but jet planimetry should be avoided due to blooming artifacts. 19 
THROMBUS DETECTION
Patients with dilated cardiomyopathy or evidence of an akinetic apex from ischemic heart disease are at risk for thrombus formation. The presence or absence of a thrombus is clinically important with regard to the use (or discontinuation) of anticoagulant therapy in these patients. If suspicion for thrombus is high, especially in technically difficult patients or when the left ventricular apex is highly trabeculated, contrast can be helpful to exclude the presence of a clot. 20, 21 When increased echo densities are evident at the apex, this may be due to artifact or represent a laminated thrombus, and contrast should be administered for better EBD. Figure 4 shows such a patient with echo irregularities at the apex, which may represent thrombus or a transducer artifact. After contrast administration, the contrast outlines the apex and thrombus, resulting in better delineation of the apex and confirming the presence of left ventricular thrombus. In situations where administration of the contrast does not opacify the borders of the apex sufficiently, more contrast or flushing the intravenous line with saline will be necessary. Additionally, the power output and mechanical index should be reduced. Electrocardiographic triggering of the image during every frame or every fourth frame may also be helpful.
Contrast administration has also been reported to better determine whether a left ventricular pseudoaneurysm or myocardial rupture is evident. 22 In each case, it was shown that after administration of the contrast agent, the presence of a pseudoaneurysm or leakage of blood into the pericardial space from myocardial rupture was clearly demonstrable.
Physical Principles of Contrast Agents and Ultrasound
Initial studies using agitated saline for creating microbubbles revealed that visualization was accom- plished by the interaction of the ultrasound beam hitting the bubble, causing it to vibrate and oscillate. As the bubble oscillates, it contracts and expands, and eventually bursts. These changes in size and bursting create frequencies with a high amplitude of backscattered ultrasound signals. When the newer, gasfilled microbubbles are stimulated with ultrasound energy, they oscillate in a nonlinear fashion and produce harmonic frequencies at two or three times the fundamental frequency. Using the harmonic image setting on the ultrasound device will send ultrasound frequencies into the tissue but will listen to both the fundamental (2 MHz) and harmonic (4 MHz) frequencies.
Harmonic imaging provides better resolution of both the left ventricular endocardial borders and enhanced cavity opacification in addition to the traditional benefit of penetration in fundamental imaging. 23 
Contrast Agents and Artifacts
The most common type of artifact encountered when using contrast is attenuation of the atrial and ventricular chambers during injections or infusion of the agent (Fig. 5 ). Attenuation results in nonvisualization of structures in the far field of the image. Injections of a smaller amount of contrast, or the use of a slower saline flush in the intravenous line, can eliminate attenuation in many patients. When problems occur with imaging specific left ventricular segments, such as the lateral wall in the apical views, it is recommended to reposition the transducer in order to have the area of interest in the center of the image and ask the patient to perform respiratory maneuvers for enhancing visualization.
Blooming artifacts occur after contrast administration while imaging with color and spectral Doppler. The contrast agent creates excess Doppler signals, which results in an overestimation of the Doppler color jet area or size. The blooming can be decreased by using much less contrast with a slower bolus, or by using a small amount of contrast agent diluted with a larger amount of saline. Another helpful technique is to assess the color and Doppler spectral signals after completing imaging for LVO. This allows some of the contrast to "wash out" of the left ventricular cavity, decreasing the oversaturation of Doppler signals.
Another artifact is the apparent absence of contrast in the left ventricle. This may, in some instances, actually represent a papillary muscle (Fig. 6 ). To avoid this artifact, the transducer can be repositioned to image the left ventricle with the papillary muscle removed from the imaging plane. This is especially important during stress echo because the motion of the papillary muscle may create a false appearance of hyperdynamic motion of the left ventricular segment.
It is not uncommon in the parasternal long-or shortaxis views, for shadowing, due to attenuation, to occur in the left ventricle from the right ventricular opacification following the first appearance of the contrast. This can be avoided during left ventricular EBD by using the apical long axis rather than parasternal long axis. Figure 7 demonstrates the use of the apical long axis substituted for the parasternal long axis during a dobutamine stress echocardiogram.
Administration for Delivery of Contrast Agents

BOLUS
This type of injection is commonly used for LVO/ EBD. The recommended dose of the contrast is slowly injected into the intravenous tubing, followed by a slow flush of normal saline (5 to 10 cc). Newer agents will have a calculated dose of contrast agent, which is dependant on patient size. Optimal LVO is achieved when attenuation is localized to the right ventricle and the left atrium.
The advantage of bolus administration is the excellent LVO and, if needed, the ability to vary the dose to achieve optimal LVO/EBD. There are also several disadvantages. Cavity attenuation is more common with bolus delivery, and LVO/EBD may require repeated injections, necessitating more than one vial of the contrast agent. These repeated injections obviously add more time to the procedure. A final disadvantage of using bolus during dobutamine stress echocardiography is that one loses cavity opacification between bolus administrations. This is especially problematic between stages, when the EBD repeatedly is lost and rebolusing is required.
CONTINUOUS INFUSION
There are multiple techniques of infusion. One technique can include use of extension tubing (12 cm in length) along with the standard intravenous line that is then connected to a 250 mL bag of 0.9% normal saline. The contrast agent is then loaded into the proximal portion of the extension tubing so that the saline is slowly infused behind the contrast agent. 24 The rate of the saline drip can be increased or decreased depending on contrast opacification desired in the left ventricle. A second method is to use a pump that provides continuous rotation and mixing of the agent with a certain amount of saline. These continuous agitation pumps can be expensive, but because of their continuous rotation, they provide a more steady state of the infusion of the contrast agent.
Another method is to mix the agent with a larger amount of saline and slowly infuse this mixture using a standard intravenous infusion pump or a line clamp dial flow. With this technique there are two considerations. First, because the "bubbles" are 1 to 7 microns in size, the intravenous pump may detect the air and will not allow continuous infusion. Second, the composition of the contrast agent may actually adhere to the intravenous tubing line. If this happens, additional saline should be used to "flush" the line or manually compress the tubing in a continuous manner to prevent contrast adherence to the intravenous line. Regardless of the infusion methods, rates will vary depending on patient imaging characteristics and setup. There are advantages and disadvantages to these infusion methods. One distinct advantage is that they allow continuous, prolonged LVO. This is especially helpful during dobutamine and exercise stress echocardiography. Rather than using repeated bolus injections for each imaging view, and during each stage, the infusion can be left on and the rate of delivery can be adjusted as needed. A lesser amount of the agent may be required and can be loaded into the intravenous extension line, providing a steady state of infusion with homogeneous, nonattenuated cavity opacification. 25, 26 Infusion has been shown to be a better method than bolus to decrease attenuation, especially in the posterior areas of the heart. 27 This method also provides continuous left ventricular endocardial border enhancement throughout all stages of the dobutamine infusion (10, 20, 30 , and 40 mcg/kg/min) rather than endocardial enhancement only during the stages that are digitally stored (rest, low dose, peak, recovery).
A disadvantage of the infusion method is that it takes longer to set up than bolus administration, for a short time of infusion, such as might be the case during routine transthoracic echocardiography. Therefore, continuous infusion may be more appropriate for stress echo. However, during dobutamine stress echocardiography, if the time to achieve peak heart rate is prolonged at the peak dose level, one may lose full LVO in recovery stages in technically difficult patients. When cavity opacification does not remain throughout recovery, the infusion rate can be increased, the line can be flushed with normal saline, or one can load a smaller amount of contrast in the intravenous line prior to beginning the dobutamine stress protocol, then load the remaining contrast at the peak dose level. Finally, it has been suggested that infusion methods may compromise the stability of the contrast agent.
DILUTION
There are multiple ways to dilute the contrast agent, including the use of normal saline or 5% dextrose in water for adequate LVO. This mixture is slowly injected into the intravenous line and may not require an additional saline flush. This can provide excellent LVO, even in those with left ventricular enlargement. Table 1 compares the advantages and disadvantages of each method. Table 2 demonstrates common dosing for the two agents currently approved by the FDA.
Ultrasound System Controls to Optimize During Contrast Administration
When using contrast to enhance the echocardiographic images, ultrasound imaging will require 
Comparison of the Dosage for Optison and Definity for Each Method of Administration
Optison Definity
Bolus .5 cc with .5 to 1 cc 10 µL/kg saline flush Infusion 3 cc of Optison with 1.3 mL mixed in a 100 mL of saline with a 50-cc bag of normal rate of 10 to 60 mg/minute saline Dilution 1 cc of contrast to 9 cc of saline optimization. Table 3 describes optimal machine settings to begin the examination. From these baseline settings, the following parameters can be changed to further optimize the ultrasound image.
The mechanical index (MI) directly correlates with the ultrasonic power output emitted from the ultrasound system to the transducer. 28 When using contrast agents for LVO, the MI should be adjusted to a range between 0.4 and 0.8. The MI can be adjusted even lower to a level of 0.1, but this level is more often used for assessment of myocardial perfusion. The lower the MI or ultrasound power, the longer is the persistence of the bubbles, whereas the higher the MI, the more microbubbles destroyed. It is important to note that decreasing the ultrasound power will also decrease the MI. Using a low MI/output ratio to decrease bubble destruction for prolonged contrast appearance in the left ventricular cavity allows for a longer amount of time to perform imaging. Figure 8 demonstrates a high MI versus a lower MI of 0.5, which allows for ideal LVO with all segments visualized. A decrease in MI will make the ultrasound image appear darker and result in less penetration. The alteration in image quality can be compensated for by increasing the overall system gain and thereby achieving an "ideal image" with the least amount of bubble destruction. Another important system consideration is optimizing the time gain compensation controls for adequate visualization of the apex (Fig. 9 ).
The focal zone or focal point is the area in the ultrasonic beam where the power is most concentrated. At the point of the focus, there is a higher beam intensity, with 25% of the peak intensity at the focus. Distal to the focal zone, there is far-field divergence. It is well known that the best image resolution is at and proximal to the focus. Because there is ultrasonic beam divergence distal to the focus, placement of the focal zone for contrast imaging is best accomplished at the level of the mitral valve annulus such as in apical views. Some ultrasound imaging systems have dual or multiple focal zones. If this feature is available, one focal point can be placed at the apex and the other at the mitral annular level.
Dynamic range or compression is the range in decibels that can be used for displaying the gray scale of received or reflected ultrasound signals. A medium dynamic range is recommended to allow greater harmonic/bubble gray-scale imaging. At a high compression level, which results in a lower dynamic range, better EBD is achieved. Figure 10 displays the extremes in using dynamic range and compression. The Postprocessing is a digital method of filtering received ultrasound signals that can also affect the image quality. There are multiple postprocessing maps that are different for each ultrasound manufacturer. The optimal map for selection with the use of contrast should be one that allows the best delineation of the myocardium in black and the left ventricular cavity in white. Avoid postprocessing maps, which enhance the extremes of returning echo signals (edge enhancement) or average nearby pixels (smoothing). The best settings for postprocessing maps to use during contrast administration are those that provide little edge enhancement or smoothing. Persistence is a method of frame averaging that also creates a smooth picture but decreases temporal resolution. It is highly recommended to not incorporate persistence during contrast imaging.
Pulse repetition frequency (PRF) is displayed on most systems and can be controlled by the Doppler ve-locity scale. The PRF is the number of times the ultrasonic crystals are pulsed per second. A higher PRF provides better resolution but lower frame rates for two-dimensional imaging. PRF should be optimized when contrast agents are used for the patient. Easier to image patients will permit use of higher PRF, but difficult patients may require lower PRF settings to allow for greater depth and penetration.
Sensitivity is the capability of the ultrasound system to recognize back-scattered signals of low reflectivity as structures instead of noise. When harmonic imaging is used, the sensitivity should be set on high to allow for the best resolution of the low amplitude echoes from the resonating microbubbles.
Future Applications of Contrast Agents
The future of contrast agents will evolve to applications such as real-time assessment of myocardial perfusion, drug delivery to specific tissue sites, growth factor delivery to the myocardium, gene delivery, and thrombolytic therapy for the potential of resolving thrombus in the coronary arteries. Real-time assessment of myocardial perfusion will strive to identify regional ischemia, myocardial effects of reperfusion, and identification of both viable and nonviable areas of myocardium. Currently, ultrasound manufacturers have released newer methods of imaging modalities for evaluating real-time perfusion including powerpulsed inversion, coherent contrast imaging, and power modulation. The evaluation of myocardial perfusion by contrast echocardiography has been shown to be feasible and appears to compare favorably with nuclear medicine techniques. [29] [30] [31] [32] 
Conclusion
The administration of intravenous contrast agents that can traverse the pulmonary capillary bed provides improved recognition of the left ventricular cavity and endocardial borders. Use of contrast agents often necessitates changes in image appearance. Each ultrasound system has various image settings for contrast enhancement. These settings are a helpful baseline that should be optimized for each patient. After image acquisition and contrast is injected, it is important to maintain a stable image position. Ideally, the image should contain a medium range of gray scale and there should be homogeneity of the cavity opacification as well as optimal image resolution and border delineation. Employing these techniques will provide optimal patient care through enhanced echocardiographic imaging.
